Organigram Holdings Inc. (OGI) Earnings Call Analysis
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
Earnings Reports
-
Organigram (OGI) Q1 2026: 49% Revenue Growth, Margin Resilience Anchors Expansion Plans
June 15, 2026
-
Organigram (OGI) Q1 2026: 49% Revenue Surge Powered by Domestic Momentum, Margin Gains Hold Amid International Disruption
June 15, 2026
-
Organigram (OGI) Q2 2026: Sanity Group Adds €25M Quarterly Run Rate as International Shift Accelerates
May 13, 2026
-
Organigram (OGI) Q4 2025: International Sales Jump 171% as Margin Expansion Accelerates
December 16, 2025
-
Organigram (OGI) Q2 2025: International Sales Surge 177% as Global Expansion Accelerates
August 13, 2025